The endogenous cannabinoid system and brain development

Trends in Neurosciences

Volumn 23, Issue 1, 2000, Pages 14-20

  Fernández Ruiz, Javier ^a   Berrendero, Fernando ^a   Hernández, Mari Luz ^a   Ramos, José A ^a  

^a Inst Univ de Drogodependencias   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CANNABINOID; CANNABINOID RECEPTOR; DOPAMINE; NEUROTRANSMITTER; OPIATE RECEPTOR; SEROTONIN;

BRAIN DEVELOPMENT; MEMORY; NEUROENDOCRINE SYSTEM; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NOCICEPTION; ONTOGENY; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR OCCUPANCY; REVIEW; SECOND MESSENGER;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CANNABINOIDS; ENDOCANNABINOIDS; HUMANS; NEUROTRANSMITTER AGENTS; PSYCHOTROPIC DRUGS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TYROSINE 3-MONOOXYGENASE;

EID: 0038400472     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(99)01491-5     Document Type: Review

References (59)

1. Di Marzo V.et al. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21:1998;521-528.
2. Mechoulam R.et al. Search for endogenous ligands of the cannabinoid receptors. Biochem. Pharmacol. 48:1994;1537-1544.
3. 2 receptors. Pharmacol. Ther. 74:1997;129-180.
4. Childers S.R., Breivogel C.S. Cannabis and endogenous cannabinoid systems. Drug Alcohol Depend. 51:1998;173-187.
5. Howlett A.C. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35:1995;607-634.
6. Herkenham M.et al. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11:1991;563-583.
7. Mailleux P., Vanderhaeghen J.J. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience. 48:1992;655-668.
8. Walters D.E., Carr L.A. Changes in brain catecholamine mechanisms following perinatal exposure to marihuana. Pharmacol. Biochem. Behav. 25:1986;763-778.
9. Walters D.E., Carr L.A. Perinatal exposure to cannabinoids alters neurochemical development in the rat brain. Pharmacol. Biochem. Behav. 29:1988;213-216.
10. Fernández-Ruiz J.J.et al. Role of endocannabinoids in brain development. Life Sci. 65:1999;725-736.
11. Fernández-Ruiz J.J.et al. Maternal cannabinoid exposure and brain development: changes in the ontogeny of dopaminergic neurons. Bartke A., Murphy L.L. Neurobiology and Neurophysiology of Cannabinoids, Biochemistry and Physiology of Substance Abuse (Vol. 4). 1992;119-164 CRC Press.
12. Fernández-Ruiz J.J.et al. Ontogenic and adult changes in the activity of hypothalamic and extrahypothalamic dopaminergic neurons after perinatal cannabinoid exposure. Palomo T., Archer T. Strategies for Studying Brain Disorders. 1994;357-390 Farrand Press.
13. Dalterio S.L. Cannabinoid exposure: effects on development. Neurobehav. Toxicol. Teratol. 8:1986;345-352.
14. Berrendero F.et al. Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development. Development. 125:1998;3179-3188.
15. Belue R.C.et al. The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicol. Teratol. 7:1995;25-30.
16. McLaughlin C.R., Abood M.E. Developmental expression of cannabinoid receptor mRNA. Dev. Brain Res. 76:1993;75-78.
17. McLaughlin C.R. 259. Cannabinoid receptors in developing rats: detection of mRNA and receptor binding Drug Alcohol Depend. 36:1994;27-31.
18. Mailleux P., Vanderhaeghen J.J. Localization of cannabinoid receptor in the human developing and adult basal ganglia. Neurosci. Lett. 148:1992;173-176.
19. Rodríguez de Fonseca F.et al. Presence of cannabinoid binding sites in the brain from early postnatal ages. NeuroReport. 4:1993;135-138.
20. Romero J.et al. Atypical location of cannabinoid receptors in white matter areas during rat brain development. Synapse. 26:1997;317-323.
21. Berrendero F.et al. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse. 33:1999;181-191.
22. 2 receptor messenger RNAs during embryonic development in the rat. Neuroscience. 82:1998;1131-1149.
23. Glass M.et al. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience. 77:1997;299-318.
24. Bouaboula M.et al. Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J. Biol. Chem. 270:1995;13973-13980.
25. 9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR 141716A [N-piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H- pyrazole-3-carboximide hydrochloride]. Biochem. Pharmacol. 51:1996;669-676.
26. 9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol. Pharmacol. 54:1998;834-843.
27. 9-Tetrahydrocannabinol increases activity of tyrosine hydroxylase in cultured fetal mesencephalic neurons. J. Mol. Neurosci. 8:1997;83-91.
28. Day N.L.et al. Effects of prenatal marijuana exposure on the cognitive development of offspring at age three. Neurotoxicol. Teratol. 16:1994;169-175.
29. Fried P.A. The Ottawa prenatal prospective study (OPPS): methodological issues and findings - it's easy to throw the baby out with the bath water. Life Sci. 56:1995;2159-2168.
30. Adams E.G.et al. Epidemiology of substance abuse including alcohol and cigarette smoking. Ann. New York Acad. Sci. 562:1989;123-132.
31. Nahas G.G. Toxicology and pharmacology. Nahas G.G. Marihuana in Science and Medicine. 1984;102-247 Raven Press.
32. Rodríguez de Fonseca F.et al. Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience. 43:1991;713-723.
33. 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain. J. Mol. Neurosci. 7:1996;291-308.
34. 9-tetrahydrocannabinol on developing serotonergic neurons. Eur. J. Pharmacol. 316:1996;39-42.
35. 9-THC) alters indolamine levels and turnover in adult male and female rat brains regions. Brain Res. Bull. 43:1997;173-178.
36. 9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA-B, but not GABA-A, receptor agonists in adult rats. Neurotoxicol. Teratol. 21:1999;277-283.
37. 9-tetrahydrocannabinol on the levels of opioid peptides, gonadotrophin-releasing hormone and substance P in the adult male rat brain. Brain Res. 525:1990;78-83.
38. 9-tetrahydrocannabinol facilitates morphine self-administration and changes μ opioid receptor binding in brain regions related to drug reinforcement in adult offspring females rats. Brain Res. 807:1998;101-109.
39. 9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats. Life Sci. 63:1998;843-850.
40. Navarro M.et al. Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. Pharmacol. Biochem. Behav. 47:1994;47-58.
41. 9-THC) leads to changes in opioid-related behavioral patterns in rats. Brain Res. 680:1995;142-147.
42. Dalterio S.L. Perinatal or adult exposure to cannabinoids alters male reproductive functions in mice. Pharmacol. Biochem. Behav. 12:1980;143-153.
43. Navarro M.et al. Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats. Behav. Brain Res. 75:1996;91-98.
44. 9-tetrahydrocannabinol alters the neurochemical response to stress in the adult Fischer-344 rat. Neurotoxicol. Teratol. 9:1987;321-326.
45. Murphy L.L.et al. Psychoactive and non-psychoactive cannabinoids and their effects on reproductive neuroendocrine parameters. Watson R.R. Biochemistry and Physiology of Substance Abuse (Vol. 2). 1990;73-94 CRC Press.
46. Specht L.A.et al. Light microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain. I. Early ontogeny. J. Comp. Neurol. 199:1981;233-245.
47. Insel T.R. The development of brain and behavior. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;683-694 Raven Press.
48. Levitt P.et al. New evidence for neurotransmitter influences on brain development. Trends Neurosci. 20:1997;269-274.
49. Berger B.et al. Transient expression of tyrosine hydroxylase immunoreactivity in some neurons of the rat neocortex during postnatal development. Dev. Brain Res. 23:1987;141-147.
50. Pares-Herbuté N.et al. Ontogeny of the metencephalic, mesencephalic and diencephalic content of catecholamines as measured by high performance liquid chromatography with electrochemical detection. Int. J. Dev. Neurosci. 7:1989;73-79.
51. Fride E., Mechoulam R. Developmental aspects of anandamide: ontogeny of response and prenatal exposure. Psychoneuroendocrinol. 21:1996;157-172.
52. 9-tetrahydrocannabinol in mice. Dev. Brain Res. 95:1996;131-134.
53. Goldman S.A., Luskin M.B. Strategies utilized by migrating neurons of the postnatal vertebrate forebrain. Trends Neurosci. 21:1998;107-113.
54. Jacobson M. Developmental Neurobiology. 1993;Plenum Press.
55. Howlett A.C.et al. The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci. 13:1990;420-423.
56. Venance L.et al. Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature. 376:1995;590-594.
57. 1 cannabinoid receptors in cultured astrocytes. Eur. J. Neurosci. 11:1999;691-699.
58. Di Marzo V.et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372:1994;686-691.
59. Guthrie S.C., Gilula N.B. Gap junctional communication and development. Trends Neurosci. 12:1989;12-16.